You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALCL

Showing 26 - 50 of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prognostic Value of New Markers in ALK-positive Large Anaplastic

Recruiting
  • Anaplastic Large Cell Lymphoma, ALK-Positive
    • Amiens, France
    • +14 more
    Jul 23, 2021

    Peripheral T-cell Lymphomas (PTCL) Trial in Taiwan (Lenalidomide and Gemcitabine (Dose level 11), Lenalidomide and Gemcitabine

    Not yet recruiting
    • Peripheral T-cell Lymphomas (PTCL)
    • Lenalidomide and Gemcitabine (Dose level 11)
    • +3 more
    • Kaohsiung, Taiwan
    • +3 more
    Nov 1, 2021

    A Study of Chinese Adults With Lymphoma

    Recruiting
    • Lymphoma
      • Beijing, Beijing, China
      • +18 more
      Nov 3, 2022

      Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,

      Recruiting
      • Cutaneous T-Cell Lymphoma
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      ALK-Positive Anaplastic Large Cell Lymphoma Trial in Zhengzhou (Crizotinib, Etoposide Capsule, Auto-HSCT)

      Unknown status
      • ALK-Positive Anaplastic Large Cell Lymphoma
      • Zhengzhou, Henan, China
        Oncology Department of The First Affiliated Hospital of Zhengzho
      Oct 12, 2018

      Relapsed or Refractory Peripheral T-Cell Lymphoma Trial in Korea, Republic of, Spain, United States (Tipifarnib)

      Completed
      • Relapsed or Refractory Peripheral T-Cell Lymphoma
      • Palo Alto, California
      • +12 more
      Apr 26, 2021

      Peripheral T-cell Lymphoma Trial in Shanghai (PD-1 antibody+ HDAC inhibitor)

      Recruiting
      • Peripheral T-cell Lymphoma
      • PD-1 antibody+ HDAC inhibitor
      • Shanghai, Shanghai, China
        Dongmei Ji
      Dec 3, 2021

      Arthritis, Rheumatoid Trial in Tokyo, Seoul (LBAL, Humira®)

      Completed
      • Arthritis, Rheumatoid
      • Tokyo, Japan
      • +1 more
      Mar 12, 2021

      Lymphoma Trial in Berne (Brentuximab Vedotin, BeEAM Regimen)

      Recruiting
      • Lymphoma
      • Brentuximab Vedotin
      • BeEAM Regimen
      • Berne, Switzerland
        Department for Medical Oncology University Hospital/Inselspital
      Feb 4, 2022

      Hyperhidrosis Trial in Salt Lake City (Aluminum Chloride 20% (deodorant), Alcohol)

      Active, not recruiting
      • Hyperhidrosis
      • Aluminum Chloride 20% (deodorant)
      • Alcohol
      • Salt Lake City, Utah
      • +1 more
      Sep 27, 2021

      Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors, Solid Tumors

      Withdrawn
      • Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma
      • +2 more
      • (no location specified)
      Mar 2, 2020

      Peripheral T Cell Lymphoma Trial in France (Chemotherapy + follow up, Chemotherapy + ASCT + follow up)

      Recruiting
      • Peripheral T Cell Lymphoma
      • Chemotherapy + follow up
      • Chemotherapy + ASCT + follow up
      • Amiens, France
      • +47 more
      Aug 2, 2022

      Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)

      Completed
      • Peripheral T-cell Lymphoma
      • Singapore, Singapore
        National Cancer Centre Singapore
      Apr 27, 2021

      Brentuximab Vedotin for IV Infusion - Special Drug Use

      Completed
      Has Results
      • Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma
      • Brentuximab vedotin (recombinant)
      • Osaka, Japan
        (unnamed)
      Jun 25, 2020

      Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma Trial in Seoul

      Completed
      • Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
        • Seoul, Gangnam-Gu, Korea, Republic of
          Samsung Medical Center
        Feb 4, 2022

        Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

        No longer available
        • Disease, Hodgkin
        • +3 more
        • brentuximab vedotin
        • Stanford, California
        • +30 more
        Sep 17, 2020

        Psychiatry Trial in Athens (Pomegranate juice)

        Enrolling by invitation
        • Psychiatry
        • Pomegranate juice
        • Athens, Attiki, Greece
          Organization Against Drugs
        May 5, 2023

        Peripheral T Cell Lymphoma, Relapse/Recurrence Trial in Belgium, France (Lacutamab, Gemcitabine, Oxaliplatine)

        Recruiting
        • Peripheral T Cell Lymphoma
        • Relapse/Recurrence
        • Antwerpen, Belgium
        • +38 more
        Dec 6, 2021

        Tumors With Aberrations in ALK, Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumor Trial in Worldwide (Ceritinib

        Terminated
        Has Results
        • Tumors With Aberrations in ALK
        • +3 more
        • Ceritinib (LDK378)
        • Brno, Czech Republic, Czechia
        • +13 more
        Dec 17, 2019

        Lymphoma, T-Cell, Cutaneous Trial in New York (AFM13)

        Completed
        • Lymphoma, T-Cell, Cutaneous
        • New York, New York
          Center for Lymphoid Malignancies
        Jul 14, 2020

        Anaplastic Large Cell Lymphoma, ALK-Positive, CD30-Positive Neoplastic Cells Present, Systemic Anaplastic Large Cell Lymphoma

        Withdrawn
        • Anaplastic Large Cell Lymphoma, ALK-Positive
        • +2 more
        • Brentuximab Vedotin
        • +3 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Oct 8, 2019

        MTHFR C677T and A1298C on High-dose Methotrexate-Related

        Completed
        • Pediatric NHL
        • High-dose MTX based chemotherapy
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Feb 23, 2020

        Evaluate Safety of McGhan Single Lumen Gel-Filled Breast

        Completed
        • Breast Augmentation
        • Breast Reconstruction
          • Beijing, Beijing, China
          • +5 more
          Sep 18, 2020

          Prospective Collection of Data in Peripheral T-Cell Lymphoma

          Completed
          • Lymphoma, T-Cell, Peripheral
            • Palo Alto, California
            • +75 more
            Jul 3, 2019

            Risk Stratification of Nodal PTCL

            Completed
            • Peripheral T-Cell Lymphoma, Not Otherwise Specified
            • +2 more
              • Jeonju, Korea, Republic of
                Chonbuk Nationla University Hospital
              Aug 5, 2019